Literature DB >> 33681779

Impact of interhospital transfer on patients undergoing endovascular thrombectomy for acute ischaemic stroke in an Australian setting.

Leon Stephen Edwards1,2, Christopher Blair1,2,3, Dennis Cordato1,2,3, Alan McDougall1,2,3, Nathan Manning2,4,5,6,7, Andrew Cheung2,4,5, Jason Wenderoth2,4,5,6, Cecilia Cappelen-Smith1,2,3.   

Abstract

OBJECTIVE: To assess the impact of interhospital transfer on the interplay between functional outcome, mortality, reperfusion rates and workflow time metrics in patients undergoing endovascular thrombectomy (EVT) for acute ischaemic stroke due to large vessel occlusion (LVO) in the anterior cerebral circulation. DESIGN SETTING AND PARTICIPANTS: This is an analysis of a prospective database of consecutive patients undergoing EVT for LVO presenting between January 2017 and December 2018 at a single Australian comprehensive stroke centre (CSC). Patients presented directly or were transferred to the CSC from 21 sites across New South Wales and the Australian Capital Territory. MAIN OUTCOME MEASURES: The main outcome measures were rate of good 90-day functional outcome (modified Rankin Scale 0-2), successful reperfusion (Thrombolysis in Cerebral Infarction scale grade 2b or 3), symptomatic intracerebral haemorrhage (sICH) and 90-day mortality. Key workflow time metric milestones were examined.
RESULTS: 154 of 213 (72%) patients were interhospital transfers. There was no significant difference in baseline characteristics including age, National Institutes of Health Stroke Scale score, intravenous thrombolysis administration or procedure time between transferred and direct presenters (all p>0.05). Transferred patients had worse 90-day functional outcome (39.6% vs 61.0%, OR 0.42, 95% CI 0.23 to 0.78), higher mortality (25.3% vs 6.8%, OR 4.66, CI 1.59 to 13.70) and longer stroke onset to treatment (groin puncture) time (298 min vs 205 min, p<0.01). Successful reperfusion rates and sICH were similar between the cohorts (96.8% vs 98.3%, and 7.8% vs 3.4%).
CONCLUSION: Interhospital transfer is associated with longer stroke onset to treatment, worse 90-day functional outcome and higher mortality compared with patients presenting directly to the CSC. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cerebrovascular; cerebrovascular disease; stroke

Year:  2020        PMID: 33681779      PMCID: PMC7903172          DOI: 10.1136/bmjno-2019-000030

Source DB:  PubMed          Journal:  BMJ Neurol Open        ISSN: 2632-6140


Introduction

Endovascular thrombectomy (EVT) is the standard of care for patients with acute ischaemic stroke (AIS) with large vessel occlusion (LVO) in the anterior cerebral circulation (ACC). Multicentre, randomised controlled trials have demonstrated the safety and efficacy of this procedure within 6 hours1–3 and in selected patients up to 24 hours from stroke onset according to advanced imaging findings.4 5 Shorter stroke onset to groin puncture time (defined as the start of treatment) and reperfusion has been associated with improved functional outcome. This effect diminishes over time.6 Primary stroke centres (PSC) are hospitals distributed across metropolitan and regional communities that offer dedicated stroke services, including intravenous thrombolysis (IVT) and stroke unit care.7 Comprehensive stroke centres (CSC) are large tertiary referral centres that have onsite 24-hour access to neurology, critical care and neurointerventional expertise, and provide additional specialised acute stroke services including EVT and neurosurgery. The current Australian model of stroke care expedites medical assessment and provides ready access to IVT at PSCs but requires transfer of patients eligible for EVT to a CSC. Australia has a unique geography. It is the earth’s sixth largest land mass and has the lowest population density in the world. There is significant variation in the density of cities and remote areas. Delivery of EVT is complex and resource-intensive.8 Treatment at high-volume centres is associated with improved functional outcome and lower mortality. To achieve an adequate EVT case load and scalability, Australia has centralised CSCs to major cities. New South Wales is the most populous state and has four CSCs which provide 24/7 EVT service to all local health districts and specialty networks. Patients may present directly to a CSC for stroke treatment or undergo interhospital transfer to a CSC, travelling a range of distances to receive EVT depending on their primary location in a metropolitan, regional or remote setting. An Australian study based in Victoria found no difference in 90-day functional outcomes between transferred and direct to CSC presenters undergoing EVT9; however, international registries have demonstrated poorer outcomes in transferred patients.10–12 New South Wales and other Australian states have different geographical challenges from Victoria. The impact of interhospital transfer on EVT workflow time metrics in Australia has not been previously studied. The present study is a retrospective analysis of a prospectively collected cohort of consecutive patients undergoing EVT for AIS due to LVO in the ACC at Liverpool Hospital (LH), a single large CSC in Sydney, New South Wales, Australia, over a 2-year period. The study aim was to determine the impact of interhospital transfer on (1) the proportion of patients with good 90-day functional outcome (defined by a modified Rankin Scale (mRS) 0–2), (2) mortality and symptomatic intracranial haemorrhage (sICH) rates, (3) successful reperfusion (defined as Thrombolysis in Cerebral Infarction (TICI) scale grade ≥2 b), and (4) key workflow time metrics.

Methods

Study population

We analysed data from the prospective observational registry of consecutive patients undergoing EVT for AIS at LH, a single CSC in Sydney, between January 2017 and December 2018. Patients with an occlusion involving the ACC (internal carotid, anterior cerebral, middle cerebral M1, M2 branches or tandem lesions) demonstrated on CT angiography who underwent EVT were included. Patients with posterior circulation or distal middle cerebral artery (M3 or M4 branches) occlusions were excluded. The study population was treated in accordance with current Australian guidelines, which strongly recommend EVT for all patients with an occlusion involving the ACC within 6 hours and in selected patients between 6 and 24 hours of stroke onset depending on favourable advanced imaging findings.13 This registry represents a real-world data set. Patients were transported to the CSC via road ambulance, helicopter and/or aeroplane depending on the patient’s hospital location. In accordance with New South Wales health policy, transferred patients were repatriated to the referring hospital within 48 hours of EVT if clinically stable. This research was completed without patient and public involvement.

Definitions and outcomes

Stroke onset was defined as the self-reported or witnessed time of onset of stroke symptoms. If this information could not be determined, then the time at which the patient was last known well was used. EVT was performed under general anaesthesia in all cases using thrombectomy devices (Solitaire, Trevo or Catch Mini), aspiration catheter or both. No patients received intra-arterial thrombolytics. Patients were categorised into direct or transfer depending on whether they initially ‘directly’ presented to the CSC or were ‘transferred’ from a PSC or regional hospital. For transferred patients the qualifying CT imaging was acquired prior to transport to the CSC. Repeat imaging prior to EVT was not routinely performed unless there was a significant clinical alteration. Poststroke 90-day mRS score was captured by certified assessors either in person or by telephone. The mRS score was dichotomised into ‘good’ (mRS 0–2) and ‘poor’ (mRS 3–6) functional outcome groups. An mRS score of 0–2 was used as a measure of functional independence consistent with other studies.10 11 Successful reperfusion was defined as TICI scale grade ≥2 b. Safety outcomes were 90-day mortality rates and the rates of sICH within 24 hours, defined as neurological deterioration by ≥4 points on the National Institutes of Health Stroke Scale (NIHSS) compared with baseline NIHSS score and parenchymal haematoma type 2.14 Workflow time metrics assessed the time interval between stroke onset and arrival at the PSC and CSC and additional times to acquisition of CT brain imaging, administration of IVT, discussion with and acceptance by the CSC for EVT, groin puncture (as a measure of treatment onset), reperfusion, and procedure duration.

Statistical analysis

Statistical analyses were performed using SAS V.9.0. Baseline characteristics including age, gender, vascular risk factors, baseline NIHSS score and IVT treatment were assessed using standard descriptive statistics. Normality of continuous variables was determined with the Shapiro-Wilk test. Univariate relationship of baseline characteristics with interhospital transfer versus direct presentation to CSC status was assessed. The Pearson’s χ2 test was used for categorical variables and the Wilcoxon rank-sum test for non-normally distributed continuous variables. A two-tailed p value of <0.05 was the cut-off for statistical significance. The dichotomised outcomes of functional independence, death, successful reperfusion and sICH were assessed with simple and multivariable logistic regression in the direct and transferred cohorts, as well as an analysis of a subgroup of transferred patients from PSCs within 30 km of the CSC. The multivariable model was adjusted for age, baseline NIHSS score, administration of IVT and stroke onset to groin puncture time. Ordinal logistic regression was used to analyse the change in 90-day mRS score. Relationship between interhospital transfer, baseline NIHSS score, age, stroke onset to groin puncture time, CT acquisition to groin puncture time and administration of IVT with good functional outcome were assessed in the total cohort and subgroup of patients with stroke onset to groin puncture <6 hours. Linear regression was used to assess the relationships between interhospital transfer status and workflow metrics. Listwise deletion was employed for analyses with missing data. All results were reported as OR with 95% CI.

Results

Two hundred and seventy patients underwent EVT in the designated time period. Thirty-seven patients were excluded due to posterior circulation (n=33), A3 (n=1) or M3 (n=3) occlusions. Twenty patients were excluded as they had achieved reperfusion at cerebral digital subtraction angiogram and did not require EVT. Two hundred and thirteen patients were included in the analysis. Of these, 154 (72.3%) were transferred from 21 sites (online supplementary appendix 1) and 59 (27.7%) presented directly to the CSC.

Baseline characteristics

There was no significant difference in the baseline characteristics, vascular risk factor profile, IVT administration or LVO location between the two groups (table 1). The median baseline NIHSS score was 17 (transferred patients) and 18 (direct), consistent with moderate to severe AIS. A similar number received IVT (39.6% vs 35.6%). There was no difference in the number of patients with a baseline mRS score >2 between the groups (3.3% vs 3.4%). Only one transferred patient was reimaged on arrival at the CSC.
Table 1

Baseline demographic and clinical characteristics of direct and transfer patient cohorts

Baseline and clinical characteristics
CharacteristicsDirect (n=59)Transfer (n=154)P value
 Age (median, years)74 (35–96)76 (29–95)0.66
 Female26 (44.1%)74 (48.1%)0.60
 NIHSS score, median18 (1–34)17 (2–42)0.32
Medical history
 Hypertension40 (67.8%)108 (70.1%)0.74
 Ischaemic heart disease17 (28.8%)42 (27.3%)0.82
 Atrial fibrillation27 (45.8%)75 (48.7%)0.70
 Diabetes16 (27.1%)35 (22.7%)0.50
 Dyslipidaemia35 (59.3%)85 (55.2%)0.59
 Previous stroke13 (22.0%)25 (16.2%)0.32
 Smoking15 (25.4%)23 (14.9%)0.07
Treatment
 IVT21 (35.6%)61 (39.6%)0.59
 GA59 (100.0%)153 (99.4%)0.54
Location of thrombus0.39
 M131 (52.5%)88 (57.1%)
 M214 (23.7%)23 (14.9%)
 ICA8 (13.6%)19 (12.3%)
 Tandem6 (10.2%)24 (15.6%)
Baseline mRS score0.96
 0–257 (96.6%)149 (96.8%)
 ≥32 (3.4%)5 (3.3%)

GA, general anaesthesia; ICA, internal carotid artery; IVT, intravenous thrombolysis; M1, segment 1 of the middle cerebral artery; M2, segment 2 of the middle cerebral artery; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; Tandem, cervical ICA and M1 or M2.

Baseline demographic and clinical characteristics of direct and transfer patient cohorts GA, general anaesthesia; ICA, internal carotid artery; IVT, intravenous thrombolysis; M1, segment 1 of the middle cerebral artery; M2, segment 2 of the middle cerebral artery; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; Tandem, cervical ICA and M1 or M2.

Clinical outcome

Transferred patients had lower rates of good functional outcome (39.6% vs 61.0%; OR 0.42, 95% CI 0.23 to 0.78) and higher mortality (25.3% vs 6.8%; OR 4.66, CI 1.59 to 13.70) than direct presenters at 90 days (table 2). There were similar findings in a subgroup analysis of patients transferred from PSCs within 30 km of the CSC (online supplementary appendix 2). There was a significant shift towards poorer 90-day mRS outcomes in transferred patients (common OR 2.33, CI 1.27 to 3.90; figure 1). There was no difference in the rate of successful reperfusion or sICH between directly presenting versus transferred patients (table 2).
Table 2

Clinical outcomes of direct and transfer patient cohorts

Clinical outcomeDirect (n=59)Transfer (n=154)ORAdjusted OR*
mRS 0–236 (61.0%)61 (39.6%)0.42 (0.23–0.78)0.27 (0.12–0.60)
Death4 (6.8%)39 (25.3%)4.66 (1.59–13.70)7.41 (2.27–24.19)
TICI 2b/358 (98.3%)149 (96.8%)0.51 (0.06–4.49)0.56 (0.06–5.12)
sICH2 (3.4%)12 (7.8%)2.41 (0.52–11.1)2.32 (0.49–10.95)

*Adjusted for age, baseline National Institutes of Health Stroke Scale score, administration of intravenous thrombolysis and stroke onset to groin puncture.

TICI 2b/3, Thrombolysis in Cerebral Infarction scale score of 2b or 3; mRS, modified Rankin Scale; sICH, symptomatic intracerebral haemorrhage.

Figure 1

Comparison of 90-day modified Rankin Scale (mRS) groups in direct and transfer patient cohorts.

Clinical outcomes of direct and transfer patient cohorts *Adjusted for age, baseline National Institutes of Health Stroke Scale score, administration of intravenous thrombolysis and stroke onset to groin puncture. TICI 2b/3, Thrombolysis in Cerebral Infarction scale score of 2b or 3; mRS, modified Rankin Scale; sICH, symptomatic intracerebral haemorrhage. Comparison of 90-day modified Rankin Scale (mRS) groups in direct and transfer patient cohorts. In the total cohort significant predictors of good functional outcome were direct presentation, lower baseline NIHSS score and younger age (table 3). In the subgroup of patients with stroke onset to groin puncture <6 hours, predictors of good functional outcome were direct presentation, lower baseline NIHSS score, younger age and reduction in the key time metrics of stroke onset and CT to groin puncture (table 3).
Table 3

Associations with good functional outcome (mRS 0–2) following endovascular thrombectomy

CharacteristicsOR (total, n=213) (CI)P valueOR (<6 hours, n=139) (CI)P value
Interhospital transfer0.42 (0.23 to 0.78)0.0060.36 (0.17 to 0.75)0.006
Baseline NIHSS score0.86 (0.82 to 0.90)<0.0010.87 (0.82 to 0.92)<0.001
Age0.96 (0.94 to 0.98)<0.0010.97 (0.95 to 1.00)0.04
Stroke onset to groin puncture, hours0.98 (0.94 to 1.02)0.360.57 (0.40 to 0.80)0.002
CT to groin puncture, hours1.00 (0.92 to 1.09)0.950.48 (0.29 to 0.80)0.005
IVT1.45 (0.83 to 2.53)0.19

‘<6 hours’ means less than 6 hours from stroke onset to groin puncture.

IVT, intravenous thrombolysis; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale score.

Associations with good functional outcome (mRS 0–2) following endovascular thrombectomy ‘<6 hours’ means less than 6 hours from stroke onset to groin puncture. IVT, intravenous thrombolysis; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale score.

Workflow time metrics

Time of first hospital arrival to CT was significantly longer for transferred patients (30 min vs 24 min, p=0.03; table 4). In transferred patients, there was an increase in time from CT to discussion with the CSC (31 min vs 16 min, p=0.02), discussion with CSC to acceptance for EVT (12 min vs 9 min, p=0.05) and time of CT to groin puncture (144 min vs 86 min, p<0.01). Time of CSC arrival to groin puncture was shorter for transferred patients (16 min vs 109 min, p<0.01).
Table 4

Comparison of workflow time metrics in direct and transfer patient cohorts

DirectTransferP value
Workflow time metrics
Door of first hospital to CT24 (15–36)30 (20–50)0.03
Door of first hospital to IVT61 (48–70)65 (52–86)0.09
CT to discussion with CSC16 (3–30)31 (17–55)0.02
Discussion with CSC to acceptance9 (6–14)12 (8–20)0.05
PSC to CSC arrival156 (125–220)
CSC arrival to groin puncture109 (100–144)16 (13–24)<0.001
CT to groin puncture86 (67–105)144 (117–179)0.002
First hospital arrival to groin puncture109 (100–144)172 (144–237)0.003
Procedure time30 (23–47)33 (21–47)0.89
Stroke onset to workflow epoch
Stroke onset to first hospital arrival100 (70–351)100 (60–340)0.87
Stroke onset to CT120 (70–193)129 (85–330)0.34
Stroke onset to first contact CSC141 (79–201)186 (118–435)0.12
Stroke onset to acceptance by CSC154 (105–573)210 (135–473)0.28
Stroke onset to IVT122 (110–150)141 (116–198)0.02
Stroke onset to CSC arrival100 (70–351)276 (205–540)<0.001
Stroke onset to groin puncture205 (153–333)298 (222–556)0.01
Stroke onset to reperfusion245 (198–357)348 (261–605)0.01

Times presented as median minutes with IQR.

CSC, comprehensive stroke centre; IVT, intravenous thrombolysis; PSC, primary stroke centre.

Comparison of workflow time metrics in direct and transfer patient cohorts Times presented as median minutes with IQR. CSC, comprehensive stroke centre; IVT, intravenous thrombolysis; PSC, primary stroke centre. Time of stroke onset to administration of IVT and groin puncture was significantly longer for transferred patients (141 min vs 122 min, p=0.02; and 298 min vs 205 min, p=0.01, respectively; table 4). Stroke onset to reperfusion time was also longer in transferred patients (348 min vs 245 min, p=0.01). There was no significant difference in procedure time between the groups (33 min vs 30 min, p=0.89).

Discussion

In this study, 72% of patients with AIS were transferred from a PSC. Transferred patients had worse 90-day functional outcomes, including higher mortality, when compared with those directly presenting to the CSC despite similar baseline characteristics and adjustment for time to groin puncture. In patients with groin puncture <6 hours, time from stroke onset and CT to groin puncture significantly correlated with functional outcome. Interhospital transfer patients had longer workflow time metrics, including stroke onset and first hospital arrival to time of administration of IVT, CT to discussion with the CSC team, and CT to groin puncture and reperfusion times. Poorer functional outcomes and increased mortality of transferred patients have been described in international studies.11 12 15 Studies have demonstrated that good outcome after EVT is time-dependent.6 We found that shorter stroke onset to treatment was a critical determinant of good functional outcome in patients with groin puncture <6 hours. This is concordant with findings from the Highly Effective Reperfusion Evaluated in Multiple Endovascular Stroke Trials Collaboration meta-analysis.6 The importance of expedited treatment in patients with groin puncture <6 hours may relate to the concept of fast and slow progression of infarction.16 Fast progressors experience rapid infarct growth with a limited window to reperfuse at-risk ischaemic tissue (penumbra). Slow progressors have a favourable collateral circulation and better tolerance of ischaemia. Slow progressors benefit from EVT due to eventual failure of collateral supply. Advanced imaging helps to identify slow progressors and is useful for patient selection for EVT in those presenting >6 hours from stroke onset. Transferred patients had significantly longer stroke onset to groin puncture and reperfusion times, a finding also reported by international studies.10–12 17 In the present study, interhospital transfer was associated with delays in workflow, including increased times from CT to contact of and acceptance by the CSC. Earlier discussion and streamlined acceptance by the CSC represent a key opportunity for workflow improvement. Transferred patients experienced delays in CT to groin puncture time. While shorter CT to groin puncture has been associated with better functional outcomes,10 18 improvement in this workflow time metric poses a major challenge. Differences in hospital protocol and resourcing are likely to contribute to the disparity in workflow metrics. LH has a 24-hour onsite stroke neurology team. Directly presenting patients receive immediate stroke assessment with routine advanced imaging and early neurointerventional specialist input. In contrast, PSC sites are more likely to rely on remote neurology and radiology services. Multiple strategies have been proposed to address unnecessary interhospital transfers and better identify patients with AIS at high risk of LVO and taking them directly to CSCs. Current prehospital clinical scales have low specificity in identifying LVO.19 Furthermore, prehospital bypass strategies are linked to delayed administration of IVT.20 Several countries have trialled mobile stroke units21 and telestroke22 services to expedite early specialist assessment and treatment. These approaches are expensive, limited in Australia and require substantial infrastructure, but may improve workflow metrics. At present, a centralised approach to EVT is the most feasible service delivery option. Australia’s unique geography and population distribution affect the generalisability of findings from interstate or international sites. Optimal hospital transport strategy varies by region.23 24 Factors influencing this strategy include distance, ratio of PSC to CSC, and access to stroke physicians and advanced imaging. Contextualising these factors is critical to coordinating interhospital transfer. The percentage of transferred patients in our study was higher than reported in international cohorts.10 25 This reflects the relatively few CSCs in New South Wales which service 8 million people over an area of 80 million square kilometres. Most previous analyses of interhospital transfer have been in denser populations of smaller total area10 with access to more CSCs.11 There were several limitations to our study. It was based on a retrospective analysis of prospectively collected data from a single centre, which limits applicability to regions with different geography and population density. We did not analyse patient outcomes according to treatment during business hours versus after hours, which has been shown to influence workflow time metrics.9 Although there was no difference in baseline characteristics between transferred and direct presenter groups, we cannot exclude a (favourable or unfavourable) selection bias in transferred patients. Despite the possibility of a favourable selection bias, transferred patients still had a worse outcome. We did not assess the impact of advanced imaging including collateral circulation, which is a surrogate marker for prognosis and stroke severity. Repatriation to the referring hospital within 48 hours of EVT is a health policy directive for CSCs in New South Wales. This practice disrupts continuity of care and potentially introduces differences in postacute management that may influence outcome.

Conclusion

Interhospital transfer of patients with AIS for EVT is associated with delays in treatment from stroke onset, worse functional outcome and higher mortality. The majority of our patients were transferred. A correlation between stroke onset to groin puncture and good functional outcome was seen in patients presenting within 6 hours of stroke onset. Improvement in workflow time metrics should always be sought, although other factors may influence outcome.
  23 in total

1.  Mechanical Thrombectomy-Ready Comprehensive Stroke Center Requirements and Endovascular Stroke Systems of Care: Recommendations from the Endovascular Stroke Standards Committee of the Society of Vascular and Interventional Neurology (SVIN).

Authors:  Joey D English; Dileep R Yavagal; Rishi Gupta; Vallabh Janardhan; Osama O Zaidat; Andrew R Xavier; Raul G Nogueira; Jawad F Kirmani; Tudor G Jovin
Journal:  Interv Neurol       Date:  2016-02-19

2.  Fast Versus Slow Progressors of Infarct Growth in Large Vessel Occlusion Stroke: Clinical and Research Implications.

Authors:  Marcelo Rocha; Tudor G Jovin
Journal:  Stroke       Date:  2017-08-09       Impact factor: 7.914

3.  Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.

Authors:  Gregory W Albers; Michael P Marks; Stephanie Kemp; Soren Christensen; Jenny P Tsai; Santiago Ortega-Gutierrez; Ryan A McTaggart; Michel T Torbey; May Kim-Tenser; Thabele Leslie-Mazwi; Amrou Sarraj; Scott E Kasner; Sameer A Ansari; Sharon D Yeatts; Scott Hamilton; Michael Mlynash; Jeremy J Heit; Greg Zaharchuk; Sun Kim; Janice Carrozzella; Yuko Y Palesch; Andrew M Demchuk; Roland Bammer; Philip W Lavori; Joseph P Broderick; Maarten G Lansberg
Journal:  N Engl J Med       Date:  2018-01-24       Impact factor: 91.245

4.  Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.

Authors:  Raul G Nogueira; Ashutosh P Jadhav; Diogo C Haussen; Alain Bonafe; Ronald F Budzik; Parita Bhuva; Dileep R Yavagal; Marc Ribo; Christophe Cognard; Ricardo A Hanel; Cathy A Sila; Ameer E Hassan; Monica Millan; Elad I Levy; Peter Mitchell; Michael Chen; Joey D English; Qaisar A Shah; Frank L Silver; Vitor M Pereira; Brijesh P Mehta; Blaise W Baxter; Michael G Abraham; Pedro Cardona; Erol Veznedaroglu; Frank R Hellinger; Lei Feng; Jawad F Kirmani; Demetrius K Lopes; Brian T Jankowitz; Michael R Frankel; Vincent Costalat; Nirav A Vora; Albert J Yoo; Amer M Malik; Anthony J Furlan; Marta Rubiera; Amin Aghaebrahim; Jean-Marc Olivot; Wondwossen G Tekle; Ryan Shields; Todd Graves; Roger J Lewis; Wade S Smith; David S Liebeskind; Jeffrey L Saver; Tudor G Jovin
Journal:  N Engl J Med       Date:  2017-11-11       Impact factor: 91.245

5.  Optimal Transport Destination for Ischemic Stroke Patients With Unknown Vessel Status: Use of Prehospital Triage Scores.

Authors:  Eckhard Schlemm; Martin Ebinger; Christian H Nolte; Matthias Endres; Ludwig Schlemm
Journal:  Stroke       Date:  2017-06-27       Impact factor: 7.914

Review 6.  Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges.

Authors:  Klaus Fassbender; James C Grotta; Silke Walter; Iris Q Grunwald; Andreas Ragoschke-Schumm; Jeffrey L Saver
Journal:  Lancet Neurol       Date:  2017-02-15       Impact factor: 44.182

7.  A randomized trial of intraarterial treatment for acute ischemic stroke.

Authors:  Olvert A Berkhemer; Puck S S Fransen; Debbie Beumer; Lucie A van den Berg; Hester F Lingsma; Albert J Yoo; Wouter J Schonewille; Jan Albert Vos; Paul J Nederkoorn; Marieke J H Wermer; Marianne A A van Walderveen; Julie Staals; Jeannette Hofmeijer; Jacques A van Oostayen; Geert J Lycklama à Nijeholt; Jelis Boiten; Patrick A Brouwer; Bart J Emmer; Sebastiaan F de Bruijn; Lukas C van Dijk; L Jaap Kappelle; Rob H Lo; Ewoud J van Dijk; Joost de Vries; Paul L M de Kort; Willem Jan J van Rooij; Jan S P van den Berg; Boudewijn A A M van Hasselt; Leo A M Aerden; René J Dallinga; Marieke C Visser; Joseph C J Bot; Patrick C Vroomen; Omid Eshghi; Tobien H C M L Schreuder; Roel J J Heijboer; Koos Keizer; Alexander V Tielbeek; Heleen M den Hertog; Dick G Gerrits; Renske M van den Berg-Vos; Giorgos B Karas; Ewout W Steyerberg; H Zwenneke Flach; Henk A Marquering; Marieke E S Sprengers; Sjoerd F M Jenniskens; Ludo F M Beenen; René van den Berg; Peter J Koudstaal; Wim H van Zwam; Yvo B W E M Roos; Aad van der Lugt; Robert J van Oostenbrugge; Charles B L M Majoie; Diederik W J Dippel
Journal:  N Engl J Med       Date:  2014-12-17       Impact factor: 91.245

8.  Clinical Scales Do Not Reliably Identify Acute Ischemic Stroke Patients With Large-Artery Occlusion.

Authors:  Guillaume Turc; Benjamin Maïer; Olivier Naggara; Pierre Seners; Clothilde Isabel; Marie Tisserand; Igor Raynouard; Myriam Edjlali; David Calvet; Jean-Claude Baron; Jean-Louis Mas; Catherine Oppenheim
Journal:  Stroke       Date:  2016-04-28       Impact factor: 7.914

9.  Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial.

Authors:  Bijoy K Menon; Tolulope T Sajobi; Yukun Zhang; Jeremy L Rempel; Ashfaq Shuaib; John Thornton; David Williams; Daniel Roy; Alexandre Y Poppe; Tudor G Jovin; Biggya Sapkota; Blaise W Baxter; Timo Krings; Frank L Silver; Donald F Frei; Christopher Fanale; Donatella Tampieri; Jeanne Teitelbaum; Cheemun Lum; Dar Dowlatshahi; Muneer Eesa; Mark W Lowerison; Noreen R Kamal; Andrew M Demchuk; Michael D Hill; Mayank Goyal
Journal:  Circulation       Date:  2016-04-13       Impact factor: 29.690

10.  Effect of Interhospital Transfer on Endovascular Treatment for Acute Ischemic Stroke.

Authors:  Esmee Venema; Adrien E Groot; Hester F Lingsma; Wouter Hinsenveld; Kilian M Treurniet; Vicky Chalos; Sanne M Zinkstok; Maxim J H L Mulder; Inger R de Ridder; Henk A Marquering; Wouter J Schonewille; Marieke J H Wermer; Charles B L M Majoie; Yvo B W E M Roos; Diederik W J Dippel; Jonathan M Coutinho; Bob Roozenbeek
Journal:  Stroke       Date:  2019-04       Impact factor: 7.914

View more
  5 in total

1.  Relationship between primary stroke center volume and time to endovascular thrombectomy in acute ischemic stroke.

Authors:  Laura C C van Meenen; Sanne J den Hartog; Adrien E Groot; Bart J Emmer; Martin D Smeekes; Arjen Siegers; Geert Jan Kommer; Charles B L M Majoie; Yvo B W E M Roos; Adriaan C G M van Es; Diederik W Dippel; H Bart van der Worp; Hester F Lingsma; Bob Roozenbeek; Jonathan M Coutinho
Journal:  Eur J Neurol       Date:  2021-09-23       Impact factor: 6.288

2.  TACTICS - Trial of Advanced CT Imaging and Combined Education Support for Drip and Ship: evaluating the effectiveness of an 'implementation intervention' in providing better patient access to reperfusion therapies: protocol for a non-randomised controlled stepped wedge cluster trial in acute stroke.

Authors:  Annika Ryan; Christine L Paul; Martine Cox; Olivia Whalen; Andrew Bivard; John Attia; Christopher Bladin; Stephen M Davis; Bruce C V Campbell; Mark Parsons; Rohan S Grimley; Craig Anderson; Geoffrey A Donnan; Christopher Oldmeadow; Sarah Kuhle; Frederick R Walker; Rebecca J Hood; Steven Maltby; Angela Keynes; Candice Delcourt; Luke Hatchwell; Alejandra Malavera; Qing Yang; Andrew Wong; Claire Muller; Arman Sabet; Carlos Garcia-Esperon; Helen Brown; Neil Spratt; Timothy Kleinig; Ken Butcher; Christopher R Levi
Journal:  BMJ Open       Date:  2022-02-11       Impact factor: 2.692

3.  Impact of interhospital transfer vs. direct admission on acute ischemic stroke patients: A subset analysis of the COMPLETE registry.

Authors:  Ameer E Hassan; Osama O Zaidat; Ashish Nanda; Benjamin Atchie; Keith Woodward; Arnd Doerfler; Alejandro Tomasello; Johanna T Fifi
Journal:  Front Neurol       Date:  2022-08-09       Impact factor: 4.086

4.  Practical utility of the ACT-FAST triage algorithm from a primary stroke centre perspective.

Authors:  Shuangyue Tan; Karen Stephens; Lan Gao; Elise Tan; Tanya Frost; Philip M C Choi
Journal:  BMJ Neurol Open       Date:  2022-09-07

5.  ELECTRA-STROKE: Electroencephalography controlled triage in the ambulance for acute ischemic stroke-Study protocol for a diagnostic trial.

Authors:  Maritta N van Stigt; Anita A G A van de Munckhof; Laura C C van Meenen; Eva A Groenendijk; Monique Theunissen; Gaby Franschman; Martin D Smeekes; Joffry A F van Grondelle; Geertje Geuzebroek; Arjen Siegers; Henk A Marquering; Charles B L M Majoie; Yvo B W E M Roos; Johannes H T M Koelman; Wouter V Potters; Jonathan M Coutinho
Journal:  Front Neurol       Date:  2022-10-03       Impact factor: 4.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.